Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE The Cys282Tyr mutation is responsible for most of the mild iron overload found in NASH and thus has a significant association with hepatic damage in these patients. 9453491

1998

dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE One subject (2.8%) with NASH was homozygous for the C282Y mutation and six (16.7%) were heterozygous, compared with 0%, and 11.2%, respectively, of controls. 10488699

1999

dbSNP: rs1799945
rs1799945
0.050 GeneticVariation BEFREE Sex (63-67% male) and age at diagnosis of NASH did not differ between those with or without HFE mutations, but men with NASH were significantly more likely than women to have the H63D mutation (15/23 vs. 3/13, p<0.05) Levels of serum ferritin, iron, transferrin saturation levels, and the degree of hepatic iron staining were significantly higher (p<0.05) in subjects with NASH who carried an HFE mutation than in those without. 10488699

1999

dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE The frequency of C282Y heterozygosity was increased in Anglo-Celtic patients with NASH compared with ethnic blood donor controls (22% vs. 9.2%; P =.035); there were no C282Y homozygotes in the NASH cohort. 12085358

2002

dbSNP: rs1799945
rs1799945
0.050 GeneticVariation BEFREE The frequencies of compound C282Y/H63D heterozygotes (n = 1) or H63D heterozygotes (n = 10) were not increased in NASH. 12085358

2002

dbSNP: rs1800206
rs1800206
0.010 GeneticVariation BEFREE Neither NASH nor genotype 1 HCV-related liver steatosis seems to be associated with the PPARalpha L162V polymorphism. 16297361

2005

dbSNP: rs1217691063
rs1217691063
0.020 GeneticVariation BEFREE According to this study, the MTHFR C677T mutation does not seem to be a risk factor for the progression of NAFL to NASH. 17356914

2007

dbSNP: rs7946
rs7946
0.020 GeneticVariation BEFREE Val175Met variant of PEMT could be a candidate molecule that determines the susceptibility to NASH, because it is more frequently observed in NASH patients and non-obese persons with Val175Met variant of PEMT are facilitated to develop NASH. 17391797

2007

dbSNP: rs1217691063
rs1217691063
0.020 GeneticVariation BEFREE To examine whether the C677T and A1298C polymorphisms of the MTHFR gene were associated with NASH, we analysed the allele and genotype distribution of the MTHFR C677T and A1298C polymorphisms in 57 well-diagnosed NASH patients, 324 healthy controls in a case-control study of Turkish subjects of Caucasian origin. 17563923

2008

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE The MTHFR A1298C polymorphism was significantly associated with NASH (chi(2) = 8.439; p = 0.015) in the total NASH patients compared with healthy controls. 17563923

2008

dbSNP: rs1799945
rs1799945
0.050 GeneticVariation BEFREE One patient with NASH</span> and one normal individual who were homozygous for H63D showed no iron overload. 17589946

2007

dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE The HFE C282Y heterozygous mutation is associated with advanced fibrosis among Caucasians with NASH. 17680648

2007

dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE In assessing the C282Y HFE gene mutation alone, the percentage of heterozygosis for C282Y was not different in subjects with NASH compared with controls. 17916170

2008

dbSNP: rs1799945
rs1799945
0.050 GeneticVariation BEFREE We have not found a significantly increased prevalence of the mutation H63D in the HFE gene in our patients with NASH. 17916170

2008

dbSNP: rs2290602
rs2290602
0.010 GeneticVariation BEFREE The frequency of the T allele of rs2290602 was significantly higher in the NASH patients than in the control subjects (p = 0.00093, allele frequency mode), and its frequency in the NASH patients tended to be higher than in the simple steatosis patients (p = 0.09). 18588668

2008

dbSNP: rs17107315
rs17107315
0.010 GeneticVariation BEFREE One subject with diffuse fatty liver disease and other with liver cirrhosis due to NAFLD had N34S mutation. 19502653

2009

dbSNP: rs7643645
rs7643645
0.010 GeneticVariation BEFREE Finally, in univariate analysis rs7643645/G was significantly associated with fatty liver disease (P<0.04), with an odds ratio of 1.457 (95% confidence interval: 1.018-2.086). 19940802

2010

dbSNP: rs738409
rs738409
0.800 GeneticVariation BEFREE Interestingly, the rs738</span>409 G allele was strongly associated with the severity of steatosis (P < 0.0001), the presence of NASH (P < 0.0001), hepatocellular ballooning (P < 0.0001), lobular inflammation (P < 0.0001), and the presence of fibrosis (P = 0.01) independently of confounders. 20648474

2010

dbSNP: rs738409
rs738409
0.800 GeneticVariation BEFREE The adiponutrin/PNPLA3 (patatin-like phospholipase domain-containing protein 3) variant I148M has recently emerged as an important marker of human fatty liver disease. 21145868

2011

dbSNP: rs738409
rs738409
0.800 GeneticVariation BEFREE Overall, the rs738409 G allele is associated with severity of NASH and occurrence of fibrosis in patients with NAFLD. 22258181

2012

dbSNP: rs12447924
rs12447924
0.010 GeneticVariation BEFREE In females, two SNPs in linkage disequilibrium from the CETP gene were associated with FLD: rs12447924 (OR 2.16, 95%CI 1.42-3.32, P=0.0003) and rs12597002 (OR=2.22, 95%CI 1.46-3.41 P=0.0002). 22414273

2012

dbSNP: rs12597002
rs12597002
0.010 GeneticVariation BEFREE In females, two SNPs in linkage disequilibrium from the CETP gene were associated with FLD: rs12447924 (OR 2.16, 95%CI 1.42-3.32, P=0.0003) and rs12597002 (OR=2.22, 95%CI 1.46-3.41 P=0.0002). 22414273

2012

dbSNP: rs738409
rs738409
0.800 GeneticVariation BEFREE Several recent genome-wide association studies have reported an association between single-nucleotide polymorphism rs738409 in the (patatin-like phospholipase domain-containing protein 3) PNPLA3 gene and FLD. 22546774

2013

dbSNP: rs738409
rs738409
0.800 GeneticVariation BEFREE Numerous studies in humans link a nonsynonymous genetic polymorphism (I148M) in adiponutrin (ADPN) to various forms of fatty liver disease and liver cirrhosis. 22560221

2012

dbSNP: rs1800562
rs1800562
0.060 GeneticVariation BEFREE Single-nucleotide polymorphism genotyping for C282Y (rs1800562) and H63D (rs1799945) HFE mutations was performed in 786 adult subjects in the NASH Clinical Research Network (CRN). 22611049

2012